Pathobiological considerations relating to the treatment of intraductal carcinoma (ductal carcinoma in situ) of the breast

Ca-A Cancer Journal for Clinicians

Volumn 47, Issue 1, 1997, Pages 52-64

  Fisher, Edwin R ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

BREAST CANCER; CALCIFICATION; CANCER INVASION; CANCER RADIOTHERAPY; CANCER SURGERY; DISEASE CLASSIFICATION; FEMALE; HUMAN; HUMAN CELL; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MASTECTOMY; PARTIAL MASTECTOMY; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TUMOR RECURRENCE;

EID: 0031027712     PISSN: 00079235     EISSN: None     Source Type: Journal    
DOI: 10.3322/canjclin.47.1.52     Document Type: Review

References (48)

1. Fisher ER, Sass R, Fisher B, et al: Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol 6): II. Relation of local breast recurrence to multicentricity. Cancer 1986;57:1717-1724.
2. Carter D, Smith RR: Carcinoma in situ of the breast. Cancer 1977;40:1189-1193.
3. Rosen PP, Senie R, Schottenfeld D, Ashikari R: Noninvasive breast carcinoma. Frequency of unsuspected invasion and implications for treatment. Ann Surg 1979;189:377-382.
4. Schwartz GF, Patchesfsky AS, Feig SA, et al: Multicentricity of non-palpable breast cancer Cancer 1980;45:2913-2916.
5. Lagios MD, Westdahl PR, Margolin FR, Rose MR: Duct carcinoma in situ. Relationship of extent of noninvasive disease to the- frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures. Cancer 1982;50:1309-1314.
6. Schwartz GF, Patchefsky AS, Finklestein SD, et al: Nonpalpable in situ ductal carcinoma of breast: Predictors of multicentricity and microinvasion and implications for treatment. Arch Surg 1989:124:29-32.
7. Fisher ER, Sass R, Fisher B, et al: Pathologic findings from the National Surgical Adjuvant Breast Project (protocol 6). I. Intraductal carcinoma (DCIS). Cancer 1986;57:197-208.
8. Fisher ER, Leeming R, Anderson S, et al: Conservative management of intraductal carcinoma (DCIS) of the breast: Collaborating NSABP investigation. J Surg Oncol 1991;47:139-147.
9. Fisher ER, Costantino J, Fisher B, et al: Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17: Intraductal Carcinoma (Ductal Carcinoma in Situ). Cancer 1995;75:1310-1319.
10. Gillis DA, Dockerty MB, Clagett OT: Preinvasive intraductal carcinoma of the breast. Surg Gynecol Obstet 1960;110:555-562.
11. Muir R: The evolution of carcinoma of the mamma. J Pathol Bact 1941;52:155-172.
12. Betsill WL Jr, Rosen PP, Ueberman PH, Robbins GF: Intraductal carcinoma. Long-term follow-up after treatment by biopsy alone. Cancer 1978;239:1863-1867.
13. Page DL, Dupont WD, Rogers IW. Landenberger M: Intraductal carcinoma of the breast: Follow-up after biopsy only. Cancer 1982;49:751-758.
14. Fisher B, Costantino J, Redmond C, et al: Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med 1993;328:1581-1586.
15. Solin LJ, Kurtz J, Fourquet A, et al: Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast. J Clin Oncol 1996;14:754-763.
16. Lewis D, Geschikter CF: Comedo carcinoma of the breast. Arch Surg 1938;36:225-244.
17. Ashikari R, Hajdu SI, Robbins GF: Intraductal carcinoma of the breast (1960-1969). Cancer 1971; 28:1182-1187.
18. Rosner D, Bedwani RN, Vana J, et al: Noninvasive breast carcinoma: Results of a national survey by the American College of Surgeons. Ann Surg 1980;192:139-147.
19. Fisher B, Anderson S, Redmond CK, et al: Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1995;333:1456-1461.
20. Bloodgood JC: Lesions of the female breast, in Binnie JF: A Treatise on Regional Surgery. Philadelphia, P. Blakiston Sons and Co. 1917, p 611.
21. Bloodgood JC: Comedo carcinoma (or comedoadenoma) of the female breast. Am J Cancer 1934;22:842-849.
22. Solin LJ, Yah IT, Kurtz J, et al: Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breast-conserving surgery and definitive irradiation: Correlation of pathologic parameters with outcome of treatment. Cancer 1993;71: 2532-2542.
23. Lagios MD, Margolin FR, Westdahl PR, Rose MR: Mammographically detected duct carcinoma in situ: Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer 1989;63:618-624.
24. Holland R, Peterse JL, Millis RR, et al: Ductal carcinoma in situ: A proposal for a neu classification. Semin Diagn Pathol 1994;11:167-180.
25. Ozzello L: Ultrastructure of intra-epithelial carcinomas of the breast. Cancer 1971;28:1508-1515.
26. Fisher ER: Ultrastructure of the human breast and its disorders. Am J Clin Pathol 1976;66:291-375.
27. Wong JH, Kopald KH, Morton DL: The impact of microinvasion on axillary nude metastases and survival in patients with intraductal breast cancer. Arch Surg 1990;125:1298-1301.
28. Royal College of Pathologists Working Group: Pathology reporting in breast cancer screening. J Clin Pathol 1991;44:710-725.
29. Solin LJ, Fowble BL, Yeh IT, el al: Microinvasive ductal carcinoma of the breast treated with breast-conserving surgery and definitive irradiation. Int J Radiat Oncol Biol Phys 1992; 23:961-968.
30. Fisher ER, Gregorio RM, Fisher B, et al: The pathology of invasive breast cancer: A syllabus derived from the findings of the National Surgical Adjuvant Breast Project (protocol no. 4). Cancer 1975;36:1-85.
31. Silverberg SG, Chitale AR: Assessment of significance of proportions of intraductal and infiltrating tumor growth in ductal carcinoma of the breast. Cancer 1973;32:830-837.
32. Seidman JD, Schnaper LA, Aisner SC: Relationship of the size of the invasive component of the primary breast carcinoma to axillary lymph node metastasis. Cancer 1995;75:65-71.
33. Wood WC: Should axillary dissection be performed in patients with DCIS? Ann Surg Oncol 1995;2:193-194. Editorial.
34. Webster's New World Dictionary of the American Language. Cleveland, NY, William Collus and World Publishing Co. Inc., 1974.
35. Fisher ER: Ductal carcinoma in situ: The National Surgical Adjuvant Breast Project (NSABP) experience, in Silverstein MJ (ed): Ductal Carcinoma in Situ. A Diagnostic and Therapeutic Dilemma. Baltimore, Williams and Wilkins, in press.
36. Stewart FW: Factors influencing the curability of cancer, in Proceedings of the Third National Cancer Conference: American Cancer Society. Philadelphia. JB Lippincott. 1957.
37. Page DL, Lagios MD: Pathologic analysis of the Naational Surgical Adjuvant Breast Project Trial: Unanswered questions remaining unanswered considering current concepts of ductal carcinoma in situ. Cancer 1995:75:1219-1222. Editorial.
38. Silverstein MJ. Lagios MD. Craig PH, et al: A prognostic index for ductal carcinoma in situ of the breast. Cancer 1996:77:2267-2274.
39. van de Vijver MJ. Peterse JL. Mooi WJ, et al: Neu-protein overexpression in breast cancer: Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer. N Engl J Med 1988:319:1239-1245.
40. Poller DN, Snead DR, Roberts EC, et al: Oestrogen receptor expression in ductal carcinoma in situ of the breast: Relationship to flow cytometric analysis of DNA and expression of the c-erbB-2 oncoprotein. Br J Cancer 1993:68:156-161.
41. Locker AP, Horrocks C, Gilmour AS,Horrocks et al: Flow cytometric and histological analysis of ductal carcinoma in situ of the breast. Br J Surg 1990: 77:564-567.
42. Fisher ER, Siderits R: Value of cytometric analysis for distinction of intraductal carcinoma of the breast. Breast Cancer Res Treat 1992:21:165- 172.
43. Schnitt SJ, Harris JR, Smith BL: Developing a prognostic index for ductal carcinoma in situ of the breast: Are we there yet? Cancer 1996:77:2189-2192. Editorial.
44. Fisher ER, Costantino J, Fisher B, et al: Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17: Five-year observations concerning lobular carcinoma in situ (LCIS). Cancer 1996:78:1403-1416.
45. Rosen. PP: Coexistent lobular carcinoma in situ and intraductal carcinoma in a single lobular-duct unit. Am J Surg Pathol 1980;4:241-246.
46. Trojani M: A Color Atlas of Breast Histo- pathology. Philadelphia. JB Lippincott Co. 1991. p 114.
47. Tavassoli FA: Pathology of the Breast. New York. Elsevier. 1992. pp 263-291.
48. Tsang WY,KJ Chan JK: Endocrine ductal carcinoma in situ (E-DCIS) of the breast: A form of lowgrade DCIS with distinctive clinicopathologic and biologic characteristics. Am J Surg Pathol 1996: 20:921-943.